ThomasDCoatesMD
Pediatric Hematology & Oncology • Los Angeles, CAPediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology
Section Head Hematology Childrens Blood and Cancer Institute, Childrens Hospital Los Angeles, Professor of Pediatrics and Pathology, USC Keck School of Medicine
Dr. Coates is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-361-2121Fax+1 323-660-7128
Education & Training
Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 1978 - 1982- Indiana University School of MedicineResidency, Pediatrics, 1975 - 1978
University of Michigan Medical SchoolClass of 1975
Certifications & Licensure
CA State Medical License 1985 - 2025
IN State Medical License 1977 - 2003- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment Start of enrollment: 2006 Feb 01
- Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions Start of enrollment: 2009 Jul 01
- Clinical Importance of Treating Iron Overload in Sickle Cell Disease Start of enrollment: 2009 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Transfusional hemosiderosis in childhood cancer patients and survivors.Jacquelyn Baskin-Miller, Susan Carson, Julie Jaffray, Craig Fletcher, Jessie Singer
Pediatric Blood & Cancer. 2024-10-01 - Significant pituitary siderosis is common in transfusion-dependent sickle cell disease.Akhila Vadivelan, Eamon K Doyle, Susan Carson, Christopher Denton, Saranya Veluswamy
Blood. 2024-09-26 - Agermlinevariant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome.Cassandra P Wang, Juanita E Ferreira, Juanita E Ferreira, Alexander Placek, Paibel Aguayo-Hiraldo
Leukemia & Lymphoma. 2024-09-01
Journal Articles
- Increased Brain Iron Deposition in Patients with Sickle Cell Disease: An MRI Quantitative Susceptibility Mapping StudyThomas D Coates, John C Wood, Benita Tamrazi, Blood
- A Novel Cross-Correlation Methodology for Assessing Biophysical Responses Associated with PainLonnie K Zeltzer, Roberta M Kato, Jon Detterich, Thomas D Coates, John Sunwoo, John C Wood, Journal of Pain Research
Abstracts/Posters
- Role of Exosomes in Hepcidin Regulation in _-ThalassemiaThomas Coates, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Lower Oxygen Saturation in the Internal Cerebral Vein of Patients with Sickle Cell Disease Revealed By Qsm-MRIThomas Coates, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Evaluating Luspatercept Responders in the Phase 3, Randomized, Double-Blind, Placebo-Controlled BELIEVE Trial of Luspatercept in Adult Beta-Thalassemia Patients (Pts) ...Thomas Coates, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- IRON: How to Manage When There is Too Much or Too Little of It61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Hemolysis and Tricuspid Regurgitation Jet Velocity Predict Mortality in Patients with Sickle Cell Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Introduction to a Review Series on Iron Metabolism and Its DisordersThomas Coates, MD, Blood
https://www.doximity.com/articles/96240f18-92a9-4256-8c87-d9707f5074e9
UpToDate, Wolters Kluwer Health - 2012-08-21 - Introduction to a How I Treat Series on Sickle Cell Disease and ThalassemiaThomas Coates, MD, Blood
https://www.doximity.com/articles/871a92cf-5f2a-47cb-b191-4e7d07f93840
UpToDate, Wolters Kluwer Health - 2012-03-22 - Introduction to a How I Treat Series on Sickle Cell Disease and ThalassemiaThomas Coates, MD, Blood
https://www.doximity.com/articles/871a92cf-5f2a-47cb-b191-4e7d07f93840
UpToDate, Wolters Kluwer Health - 2012-11-19 - Join now to see all
Press Mentions
- Researchers at Children’s Hospital Los Angeles Are Unraveling the Biological Mechanism That Triggers Pain in People with Sickle Cell Disease—and Confirming What Mothers Have Been Saying All AlongJanuary 10th, 2022
- Here Are the Best and Worse Case Scenarios for Omicron. Both Are BadDecember 27th, 2021
Overview of Beta ThalassemiaJanuary 31st, 2020- Join now to see all
Grant Support
- Southern California Blood Safety Surveillance Program In Hematological DisorfersCenters For Disease Control And Prevention2012
- Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2009–2011
- Sickle Cell Scholar ComponentNational Heart, Lung, And Blood Institute2008–2011
- Impact Of Blood Viscosity On Oxygen Delivery In Humans With Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2008–2011
- Administration CoreNational Heart, Lung, And Blood Institute2008–2011
- Research Initiatives For The Preventions Of Complications Of ThalassemiaCenters For Disease Control And Prevention2007–2011
- Human Models Of Sickle Cell Vascular DamageNational Center For Research Resources2006–2009
- Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2008
- Human Models Of Sickle Cell Vascular Damage: (AIM2) Response Of Plasma MarkersNational Center For Research Resources2006
- Human Models Of Sickle Cell Vascular DamageNational Heart, Lung, And Blood Institute2003–2006
- Modeling Of Neutrophil MotilityNational Center For Research Resources1999–2002
- Leukocyte Activation And Rheology In Sickle Cell Disease--Vascular OcclusionNational Heart, Lung, And Blood Institute1998–2002
- Granules And Organelles And Leukocyte ActivationNational Institute Of Allergy And Infectious Diseases1995–1998
- Neutrophil Activation And Rheology In Sickle Cell Disease--Vascular OcclusionNational Heart, Lung, And Blood Institute1996–1997
- Core--Data CoordinatingNational Heart, Lung, And Blood Institute1996–1997
- Role Of Granules &Organelles In Leukocyte ActivationNational Institute Of Allergy And Infectious Diseases1988–1992
- Role Of Granules And Organelles In Leukocyte ActivationNational Institute Of Allergy And Infectious Diseases1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
